RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy is a research paper published in Cell stem cell (2021). On theSindex it has a DataRank of 2.1. It has been cited 76 times, with 63 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.652
From this paper's citation signal
Citation Network Contribution
1.4
From 52 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 63 citers.
American Heart Association
Grant: 18TPA34230105
Fondation Leducq
Grant: 19CVD02
Michael Smith Foundation for Health Research
Grant: R33 HL123655
NCI
Grant: R01 CA220002
NCI
Grant: R01 CA261898
NHLBI
Grant: K99/R00 HL121177
NHLBI NIH HHS
Grant: R00 HL121177
NHLBI NIH HHS
Grant: K99 HL121177
NCATS NIH HHS
Grant: TL1 TR001423
Canadian Institutes of Health Research
Grant: unidentified
unidentified
Provincial Health Services Authority
Genome Canada
Canadian Institutes of Health Research
Genome British Columbia
CIHR
National Institutes of Health
Canadian Cancer Society
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals